Umbilical Cord Blood (UCB) Stem Cell Market 2022 CAGR Value, Business Development, Upcoming Trends, Demand, Types, Applications and Share Forecast to 2026 [MarketWatch]
PLUS THERAPEUTICS, Inc. (PSTV)
Company Research
Source: MarketWatch
The MarketWatch News Department was not involved in the creation of this content. Jan 12, 2022 (The Expresswire) -- “ Umbilical Cord Blood (UCB) Stem Cell Market ” report provides the detailed study of Porter's Five Forces analysis, competitor landscape, development trends, product scope, detailed cost analysis, growth opportunities. Umbilical Cord Blood (UCB) Stem Cell Market includes breakdown data by manufacturers, strategy analysis, market challenges and risks, growth opportunities, macroscopic indicators, salesand revenue byproduct. Get a Sample Copy of the Report - http://www.industryresearch.co/enquiry/request-sample/18748931 The Umbilical Cord Blood (UCB) Stem Cell market revenue was million USD in 2016, grew to million USD in 2020, and will reach million USD in 2026, with a CAGR of during 2020-2026. List of Top Key Players in Umbilical Cord Blood (UCB) Stem Cell Market Report Are: - ? Advanced Cell Technology ? California Stem Cell ? Cytori Therapeutics ? Geron Corpo
Show less
Read more
Impact Snapshot
Event Time:
PSTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSTV alerts
High impacting PLUS THERAPEUTICS, Inc. news events
Weekly update
A roundup of the hottest topics
PSTV
News
- Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense [Yahoo! Finance]Yahoo! Finance
- Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of DefenseGlobeNewswire
- Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management TeamGlobeNewswire
- Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual ConferenceGlobeNewswire
PSTV
Earnings
- 10/31/23 - Miss
PSTV
Sec Filings
- 3/14/24 - Form 8-K
- 3/13/24 - Form 8-K
- 3/8/24 - Form S-1/A
- PSTV's page on the SEC website